Applications of 4-Methyl-2-Quinolinamine in Industrial Manufacturing

4-Methyl-2-Quinolinamine serves as an essential intermediate for specialty chemicals manufacturing across several technically demanding sectors. The following detailed applications outline its industrial roles based on real downstream use cases, strict adherence to manufacturing requirements, and established industry standards.

1. Pharmaceutical Intermediate for Antimalarial API Synthesis

This compound is widely used in synthesizing key intermediates for antimalarial active pharmaceutical ingredients, particularly in the production of chloroquine derivatives. Manufacturers rely on its high purity in multi-step processes to ensure batch consistency and regulatory compliance. Utilization requires thorough traceability and adherence to stringent pharmacopeial specifications, with batch records linking API origin, process steps, and in-process controls to meet end-use medication safety requirements.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients
• USP-NF Monographs for relevant APIs
• EU GMP Part II requirements
• WHO Prequalification of Medicines Programme (as relevant for malaria drugs)

Typical usage ratio

• Ranges from 0.7 to 1.2 molar equivalents relative to the condensation reagent, depending on target API yield and impurity control.

Downstream process integration

• Introduced after the initial quinoline framework assembly; reacts in amination or alkylation steps to form specific side chains in the API molecule.

Final product types

• Bulk antimalarial actives such as hydroxychloroquine and chloroquine phosphates
• Finished antimalarial tablets and injectables
• Generic and branded formulations for government or NGO procurement

2. Dye and Pigment Intermediate for Specialty Colorant Manufacture

Within the dyestuff sector, 4-Methyl-2-Quinolinamine acts as a building block for synthesizing quinoline-based pigments and color-fast dyes. These pigments provide stable, high-performance coloring agents for inks, plastics, and specialty textiles, where thermal stability and tinting strength are critical. Trace metal content, isomer ratio, and residual acidity require monitoring during scale-up to maintain color reproducibility in final applications.

Industry compliance standards

• OEKO-TEX Standard 100 for restricted substances in textile dyes
• EU REACH Regulation (EC) No 1907/2006 for substance registration and documentation
• ISO 9001:2015 Quality Management System for process traceability
• ASTM D7682 for colorant analysis in ink applications

Typical usage ratio

• Typically 3 – 7% by weight of reaction mixture, depending on color shade and target pigment loading. Adjusted according to pigment concentration required for end-use formulation.

Downstream process integration

• Enters as a primary amine component during the nucleophilic aromatic substitution or cyclization stage in pigment molecule synthesis.

Final product types

• Quinoline-based pigments for plastics and rubber compounds
• High-performance textile dyes
• Solvent-based and water-based industrial inks
• Printing color concentrates

3. Agrochemical Synthesis Intermediate

The chemical is used as an essential intermediate in producing specific fungicidal and bactericidal crop protection agents. Agrochemical manufacturers require reliable sourcing and full batch documentation to meet field use and export regulatory standards. Strict attention to residual content, by-product formation, and compatibility with downstream formulation adjuvants is monitored throughout synthesis and final blending.

Industry compliance standards

• FAO/WHO Codex Alimentarius for pesticide residue limits
• ISO 17025 for laboratory analysis of technical grade raw materials
• Regulation (EC) No 1107/2009 on plant protection product authorization
• US EPA Registration Guidelines for new active substances

Typical usage ratio

• 0.5 – 1.0 molar equivalents, tailored according to desired active vs. by-product control, and the specific synthetic route for the crop protection molecule.

Downstream process integration

• Reacted at the alkylation or condensation stage to introduce functional groups necessary for the pesticidal activity; followed by purification before final formulation.

Final product types

• Technical grade fungicides and bactericides for seed treatment
• Finished crop protection formulations (e.g., emulsifiable concentrates, water dispersible granules)
• Pre-mixed agrochemical cocktails for integrated pest management systems

4. Intermediate for Fluorescent Marker Synthesis in Diagnostics

Diagnostic reagent manufacturers use this compound in preparing fluorescence markers for clinical assays and biochemistry analyzers. Its integration ensures high purity and strong luminescence for sensitive detection in quantitative analytical kits. Quality control focuses on limiting trace impurities and validating lot-to-lot consistency for downstream FDA and CE regulatory acceptance.

Industry compliance standards

• ISO 13485:2016 for medical device quality management system
• FDA 21 CFR Part 820 for medical device and diagnostic reagent manufacturing
• EU IVDR (Regulation (EU) 2017/746) for in vitro diagnostic reagents
• Single-use and chemical traceability protocols per customer requirement

Typical usage ratio

• 0.2 – 0.5 molar equivalents relative to the key fluorophore framework, with ratio adjusted for the intended emission wavelength and assay sensitivity.

Downstream process integration

• Added in condensation step during chromophore preparation; followed by purification and coupling to biorecognition agents or antibodies.

Final product types

• Fluorescent molecular probes
• Diagnostic assay kits for immunofluorescence
• Quantitative analytical substrates for clinical chemistry
• Research use only (RUO) fluorescence reagents

5. API Intermediate for Central Nervous System (CNS) Drugs

4-Methyl-2-Quinolinamine is applied in multi-step syntheses of intermediates for CNS pharmacological agents, especially where quinoline scaffolds are central to neurological activity. Production necessitates managing isomeric and chiral purity within narrowly controlled parameters. Compliance throughout synthesis and final API isolation adheres to regional and international pharma regulatory frameworks.

Industry compliance standards

• USP, Ph. Eur., or JP monographs for CNS drug substances
• FDA Current Good Manufacturing Practices (21 CFR Parts 210 & 211)
• ICH Q3A/B for impurity profiles in APIs
• International Narcotics Control Board import/export controls (where applicable)

Typical usage ratio

• Varies between 0.85 and 1.1 molar stoichiometry, driven by downstream transformation efficiency, intermediate isolation, and impurity formation monitoring.

Downstream process integration

• Enters the synthetic pathway post-core quinoline derivatization, often as a functionalizing amination agent during precursor conversion.

Final product types

• Bulk CNS-active pharmaceutical ingredients
• Neurological disorder treatments (tablets, capsules, injectables)
• Intermediate compounds for further pharmaceutical synthesis

6. Intermediate for Fine Chemical and Electronic Material Additives

The compound is implemented in fine chemicals production where quinoline derivatives function as specialty additives in liquid crystals, OLED emitters, or charge transport materials. Electronic materials manufacturers require extremely low contaminant levels, batch documentation, and consistent physical properties to maintain device performance standards. Integration steps demand rigorous solvent control and trace level metal analysis.

Industry compliance standards

• ISO 9001:2015 for supply chain traceability
• IEC 61249-2-21 for halogen-free requirements in electronics
• RoHS Directive 2011/65/EU limiting hazardous substances
• Customer-managed testing protocols for sensitive additive applications

Typical usage ratio

• From 0.3 to 1.0% by weight in active blends, customized according to desired performance properties and downstream blending conditions.

Downstream process integration

• Added during initial condensation or polymer backbone extension stages; followed by high-purity filtration and formulation into liquid matrix or polymer layer.

Final product types

• Display and electronic device additives (liquid crystal modifiers)
• OLED emitters and transport layer compounds
• Sensor and transducer specialty layers